Advertisement
Screener

TELEFLEX INCORPORATED (TFX) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases

2.8 / 5 stars · 68/120 Roast Me

TELEFLEX INCORPORATED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases

TELEFLEX INCORPORATED (TFX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases of $15.51 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.

Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases · last filed 2026-02-27

  • TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2020-12-31 was $3.06M.
  • TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2018-09-30 was $0.00.
  • TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2025 was $15.51M, a 6469.92% increase from fiscal 2024.
  • TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2024 was $236.00K, a 94.50% decline from fiscal 2023.
  • TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2023 was $4.29M, a 38.45% decline from fiscal 2022.
  • TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2022 was $6.97M, a 77.98% decline from fiscal 2021.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 12 month
2025-12-31$15.51M
10-K · filed 2026-02-27
2024-12-31$236.00K
10-K · filed 2026-02-27
2023-12-31$4.29M
10-K · filed 2025-02-28
2022-12-31$6.97M
10-K · filed 2024-02-23
2021-12-31$31.68M
10-K · filed 2023-02-23
2020-12-31$3.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$146.97M
10-K · filed 2022-03-01
2020-09-27$143.91M
10-Q · filed 2020-10-29
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$396.00K
10-Q · filed 2018-11-01
2018-07-01$396.00K
10-Q · filed 2018-08-02
2017-10-01$5.37M
10-Q · filed 2017-11-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55